Up to 20% of stroke cases in young adults occur in those with cervical artery dissection, the leading cause of stroke in this population.
Clinicians should closely monitor patients with atrial fibrillation, especially if they are female and of increasing age.
Efficacy of triple antiplatelet therapy compared with current guideline-based therapy for the prevention of recurrent stroke was evaluated in the TARDIS trial.
The results provide good evidence for the use of contact aspiration in ischemic stroke.
Delays related to the determination of treatment eligibility increased door-to-needle times by more than 30 minutes compared with patients with no delays.
Neither lying flat nor sitting up appears to alter outcomes in patients presenting with acute stroke.
The difference in rate of recurrence of PCAIS may have to do with a difference in mechanism compared with ACAIS.
Use of advanced imaging may help predict which patients will have an optimal response to treatment with intravenous tissue plasminogen activator.
Migraine affects approximately 20% of the general population and is associated with an increased risk for ischemic stroke.
Intravenous thrombolysis prior to mechanical thrombectomy did not benefit patients with acute ischemic stroke due to a large vessel occlusion.
Warfarin protected against ischemic stroke, major bleeding, and all-cause mortality in patients who continued to take the drug after dementia diagnosis.
The triple-validated SeLECT score may help identify patients suited for antiepileptic drug trials.
Women with a history of migraine headache had a more than 2-fold increased risk of stroke over a 6-year follow-up period.
Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.
Another class of antacids, H2 receptor antagonists, had no impact on stroke risk.
Serious adverse events, especially those requiring hospitalization, may indicate an elevated risk of stroke.
The neuroprotective effect was evident after at least 6 months of use.
Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.
Patients with acute ischemic stroke experienced less disability when treated with early endovascular thrombectomy.
Cerebral microbleeds increase the risk for symptomatic ICH after thrombolysis for acute ischemic stroke.
Being overweight may slightly lower chances for hemorrhagic stroke, the study found.
The Trevo devices are the first to be indicated for use in conjunction with IV tPA.
Studies have linked GCA with increased risk of VTE; however, results have been compromised by limited data sets.
Four blood biomarkers are associated with an increased risk of ischemic stroke.
In mice, the protein triggered the stem cells to become functioning neurons.
Associations with increased mortality were found for both low and high hemoglobin levels, suggesting a U-shaped relationship.
The findings are relevant for patients with insulin resistance but no history of diabetes.
Incidence of ischemic stroke does not appear to be influenced by exposure to tumor necrosis factor(TNF)-inhibitor use in patients with rheumatoid arthritis.
Still, regional variations exist, indicating that more personalized prevention programs may be needed.
Time, however, still plays a big role in stroke outcomes.
Neurology Advisor Articles
- New Sleep Apnea Clinical Practice Guidelines
- International League Against Epilepsy Updates Epilepsy Classification System
- Patent Foramen Ovale Closure Reduces Stroke Risk in Patients With Inherited Thrombophilias
- In Refractory Status Epilepticus, Lacosamide May Be a Good Option
- The Handoff: Your Week in Neurology News - 3/23/17